Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Niche01:26

Stem Cell Niche

6.6K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Backbone-Length-Optimized Inhibitors Deliver Long-Retention Selectivity in Area-Selective ALD of VO<sub>2</sub>.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Regenerative effects of myogenic gene transfected MSC derived exosomes on radiation esophagitis.

Tissue engineering and regenerative medicine·2026
Same author

Trends in Contact Sensitization Among Korean Patients: A Multicenter 6-Year Retrospective Patch Test Study.

Contact dermatitis·2026
Same author

Multiplex Real-Time PCR Detection of Salmonella enterica Serovars in Egg Matrices: A Comparative Genomics Approach and Inhibition Assessment.

Journal of food protection·2026
Same author

Oral and Intranasal Administration of Polydeoxyribonucleotide Isolated from <i>Porphyra</i> sp. Ameliorates Acute Lung Injury via Suppressing Proinflammatory Cytokine Production in Mice.

Current issues in molecular biology·2026
Same author

Current Clinical Perspectives on Rosacea Management: Insights From a Korean Multicenter Expert Opinion Survey.

Annals of dermatology·2026

Related Experiment Video

Updated: Apr 6, 2026

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

12.4K

Stem cell niche as a prognostic factor in leukemia.

Ga-Young Lee1, Jin-A Kim1, Il-Hoan Oh1

  • 1The Catholic High-Performance Cell Therapy Center & Department of Medical Lifescience, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.

BMB Reports
|July 23, 2015
PubMed
Summary

Leukemia alters bone marrow stromal cells, impacting normal blood cell growth and promoting cancer. These stromal changes predict patient outcomes, offering a new prognostic biomarker for acute myeloid leukemia.

More Related Videos

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells
08:34

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells

Published on: September 28, 2022

6.2K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K

Related Experiment Videos

Last Updated: Apr 6, 2026

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

12.4K
Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells
08:34

Flow Cytometry Analysis of Murine Bone Marrow Hematopoietic Stem and Progenitor Cells and Stromal Niche Cells

Published on: September 28, 2022

6.2K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.9K

Area of Science:

  • Hematology
  • Cancer Biology
  • Stem Cell Biology

Background:

  • The bone marrow (BM) microenvironment plays a critical role in regulating hematopoietic cells.
  • Limited understanding exists regarding the specific alterations within the BM niche of leukemia patients.
  • Mesenchymal stromal cells (MSCs) are key components of the BM niche, influencing hematopoiesis and disease progression.

Purpose of the Study:

  • To investigate the alterations in bone marrow mesenchymal stromal cells (MSCs) in patients with acute myeloid leukemia (AML).
  • To determine how leukemic blasts reprogram MSCs and remodel the niche crosstalk.
  • To explore the correlation between BM stromal remodeling and the clinical course of AML.

Main Methods:

  • Analysis of bone marrow samples from AML patients.
  • Transcriptomic profiling of mesenchymal stromal cells (MSCs).
  • Assessment of niche crosstalk and its impact on normal hematopoietic cells.
  • Correlation of stromal remodeling patterns with clinical outcomes, including remission and relapse.

Main Results:

  • Leukemic blasts alter MSCs in a manner dependent on the clinical course of AML.
  • Leukemic blasts reprogram MSC transcriptomes and remodel niche crosstalk.
  • This remodeling selectively suppresses normal primitive hematopoietic cells while supporting leukemogenesis and chemoresistance.
  • Specific patterns of BM stromal remodeling correlate with AML prognosis: low mesenchymal progenitors predict long remission, while high mesenchymal progenitor or MSC content predicts relapse.

Conclusions:

  • Leukemic cell-induced stromal remodeling is integral to leukemogenesis and the dominance of leukemic cells.
  • Altered bone marrow stromal cells in AML can serve as a predictive biomarker for patient prognosis.
  • Understanding these interactions opens avenues for novel therapeutic strategies targeting the leukemia niche.